NET PROFIT (x1000 EUR)
EMPLOYEES
Expres2ion Biotechnologies ApS
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
0
|
0
|
0 |
| Earnings before taxes |
-8,202
|
-11,383
|
-3,998 |
| Total assets |
6,737
|
12,240
|
14,305 |
| Current assets |
6,056
|
12,018
|
14,075 |
| Current liabilities |
981
|
2,844
|
888 |
| Equity capital |
5,626
|
9,216
|
13,080 |
| - share capital |
71
|
71
|
71 |
| Employees (average) |
15
|
15
|
15 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
83.5%
|
75.3%
|
91.4% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) | |||
| Current ratio |
617.3%
|
422.6%
|
1585.0% |
| Return on equity (ROE) |
-145.8%
|
-123.5%
|
-30.6% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.